Total Payments
$847.19
2024 Payments
$130.20
Companies
13
Transactions
24
Medicare Patients
334
Medicare Billing
$40,036
Payment Breakdown by Category
Education$465.22 (54.9%)
Food & Beverage$381.97 (45.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $465.22 | 5 | 54.9% |
| Food and Beverage | $381.97 | 19 | 45.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $194.00 | 2 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $126.54 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $115.58 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $93.99 | 5 | $0 (2024) |
| Seagen Inc. | $52.65 | 2 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $38.46 | 1 | $0 (2023) |
| ARRAY BIOPHARMA INC | $36.21 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $26.29 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $18.41 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.20 | 7 | E.R. Squibb & Sons, L.L.C. ($93.99) |
| 2023 | $185.08 | 9 | Janssen Biotech, Inc. ($55.59) |
| 2022 | $22.88 | 1 | Seagen Inc. ($22.88) |
| 2021 | $29.77 | 1 | Seagen Inc. ($29.77) |
| 2020 | $99.00 | 1 | Amgen Inc. ($99.00) |
| 2019 | $95.00 | 1 | Amgen Inc. ($95.00) |
| 2018 | $271.22 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($111.24) |
| 2017 | $14.04 | 1 | Celgene Corporation ($14.04) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: Oncology | ||||||
| 06/24/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Oncology | ||||||
| 06/18/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Oncology | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Oncology | ||||||
| 02/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Oncology | ||||||
| 02/05/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Oncology | ||||||
| 11/20/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $26.29 | General |
| 05/16/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Oncology | ||||||
| 04/26/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 04/24/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Oncology | ||||||
| 02/23/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $38.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/25/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Oncology | ||||||
| 06/09/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Oncology | ||||||
| 11/08/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Oncology | ||||||
| 04/28/2020 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 01/31/2019 | Amgen Inc. | — | Education | In-kind items and services | $95.00 | General |
| 10/30/2018 | Takeda Pharmaceuticals U.S.A., Inc. | VELCADE (Drug) | Education | In-kind items and services | $111.24 | General |
| Category: Oncology | ||||||
| 10/09/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/24/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Oncology | ||||||
| 10/20/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 100 | 120 | $37,176 | $11,325 |
| 2022 | 6 | 189 | 246 | $54,931 | $23,812 |
| 2021 | 3 | 45 | 51 | $10,008 | $4,899 |
Total Patients
334
Total Services
417
Medicare Billing
$40,036
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 56 | $17,428 | $4,709 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 22 | $9,541 | $2,852 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,320 | $2,060 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,773 | $1,592 | 42.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 19 | $114.00 | $111.72 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 91 | $21,519 | $9,513 | 44.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $12,238 | $5,081 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 31 | $10,093 | $4,589 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,889 | $3,100 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,862 | $1,366 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 55 | $330.00 | $163.17 | 49.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 17 | $5,151 | $2,654 | 51.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,719 | $2,175 | 46.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 23 | $138.00 | $69.00 | 50.0% |
About Dr. Iris Sheng, M.D
Dr. Iris Sheng, M.D is a Hematology & Oncology healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2015. The National Provider Identifier (NPI) number assigned to this provider is 1578942058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iris Sheng, M.D has received a total of $847.19 in payments from pharmaceutical and medical device companies, with $130.20 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Education" ($465.22).
As a Medicare-enrolled provider, Sheng has provided services to 334 Medicare beneficiaries, totaling 417 services with total Medicare billing of $40,036. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Cambridge, MA
- Active Since 05/29/2015
- Last Updated 10/08/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578942058
Products in Payments
- VELCADE (Drug) $111.24
- ERLEADA (Drug) $69.22
- IMBRUVICA (Drug) $59.99
- OPDIVO (Biological) $57.67
- ZEPZELCA (Drug) $38.46
- OPDUALAG (Drug) $36.32
- ADCETRIS (Biological) $29.77
- TUKYSA (Drug) $22.88
- LORBRENA (Drug) $21.68
- PLUVICTO (Drug) $18.41
- KEYTRUDA (Biological) $17.40
- ALUNBRIG (Drug) $15.30
- XALKORI (Drug) $14.53
- Abraxane (Drug) $14.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cambridge
Robert Fram, M.d, M.D
Hematology & Oncology — Payments: $159,285
Hematology & Oncology $159,285
Jeffrey Jones, M.d, M.D
Hematology & Oncology — Payments: $20,956
Hematology & Oncology $20,956
Debashish Misra, M.d, M.D
Hematology & Oncology — Payments: $456.08
Hematology & Oncology $456.08
Dr. Thomas Caughey, Md, MD
Hematology & Oncology — Payments: $420.08
Hematology & Oncology $420.08
Dr. Nabiel Alkhouri, M.d, M.D
Hematology & Oncology — Payments: $377.33
Hematology & Oncology $377.33
Anna Berkenblit, M.d, M.D
Hematology & Oncology — Payments: $67.56
Hematology & Oncology $67.56